Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Tuesday, May 16 2023
01:50 PM – 02:10 PM PT

FDA’s Assessment of CGT Manufacturing Changes and Comparability Data

Tal Salz. Dark Horse Consulting Group, CA

Disclosures: T. Salz: None.

© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.